J Crétin

748 total citations
31 papers, 257 citations indexed

About

J Crétin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J Crétin has authored 31 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J Crétin's work include Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). J Crétin is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). J Crétin collaborates with scholars based in France, Switzerland and Canada. J Crétin's co-authors include Éric Pujade-Lauraine, Gilles Freyer, B. Weber, D. Paraïso, J. Provençal, Claire Falandry, Jennifer Martin, Olivier Trédan, R. Delva and Laëtitia Stefani and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

J Crétin

27 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Crétin France	8	94	72	70	40	38	31	257
Aude-Marie Savoye France	7	159 1.7×	34 0.5×	82 1.2×	40 1.0×	14 0.4×	19	312
Breton Roussel United States	8	82 0.9×	93 1.3×	23 0.3×	74 1.9×	12 0.3×	21	327
J. Van Loon Netherlands	8	67 0.7×	38 0.5×	39 0.6×	37 0.9×	94 2.5×	20	258
Akiko Abe Japan	12	51 0.5×	52 0.7×	157 2.2×	129 3.2×	9 0.2×	35	307
Alexandra Leconte France	9	63 0.7×	91 1.3×	30 0.4×	42 1.1×	13 0.3×	30	288
Bo Grønlund Denmark	11	118 1.3×	42 0.6×	246 3.5×	159 4.0×	15 0.4×	25	394
N. Olmeo Italy	11	206 2.2×	46 0.6×	219 3.1×	17 0.4×	90 2.4×	23	508
G Tripsianis Greece	11	154 1.6×	194 2.7×	18 0.3×	161 4.0×	27 0.7×	14	384
Jochen Wilke Germany	8	98 1.0×	30 0.4×	73 1.0×	72 1.8×	8 0.2×	21	265

Countries citing papers authored by J Crétin

Since Specialization

Citations

This map shows the geographic impact of J Crétin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Crétin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Crétin more than expected).

Fields of papers citing papers by J Crétin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Crétin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Crétin. The network helps show where J Crétin may publish in the future.

Co-authorship network of co-authors of J Crétin

This figure shows the co-authorship network connecting the top 25 collaborators of J Crétin. A scholar is included among the top collaborators of J Crétin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Crétin. J Crétin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luna, Gonzalo De, J Crétin, Rabah Redjoul, et al.. (2025). Screening for clonal hematopoiesis in patients with β-hemoglobinopathies who are candidates to transplant approaches. Blood. 146(Supplement 1). 534–534.

Guérif, S., R. de Crevoisier, G. Calais, et al.. (2024). Short-Term Androgen Deprivation Therapy and High-Dose Radiotherapy in Intermediate- and High-Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S4–S5. 1 indexed citations

Crétin, J, et al.. (2023). A Non-Coding Fc Gamma Receptor Cis-Regulatory Variant within the 1q23 Gene Cluster Is Associated with Plasmodium falciparum Infection in Children Residing in Burkina Faso. International Journal of Molecular Sciences. 24(21). 15711–15711.

Falandry, Claire, Étienne Brain, Marc Bonnefoy, et al.. (2013). Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial. European Journal of Cancer. 49(13). 2806–2814. 28 indexed citations

Dubray, Bernard, V. Beckendorf, S. Guérif, et al.. (2011). Does short-term androgen depletion add to high-dose radiotherapy (80 Gy) in localized intermediate-risk prostate cancer? Intermediary analysis of GETUG 14 randomized trial (EU-20503/NCT00104741).. Journal of Clinical Oncology. 29(15_suppl). 4521–4521. 29 indexed citations

Falandry, Claire, Étienne Brain, Marc Bonnefoy, et al.. (2011). Impact of geriatric vulnerability parameters on pegylated liposomal doxorubicin (PLD) tolerance and outcome in elderly patients with metastatic breast cancer: Results of the DOGMES multicenter phase II GINECO trial.. Journal of Clinical Oncology. 29(15_suppl). 9122–9122. 6 indexed citations

Provençal, J., Claire Cropet, Valérie Delecroix, et al.. (2011). 5005 ORAL Exploratory Subgroup Analysis of the TAMRAD Phase 2 GINECO Trial Comparing Tamoxifen (TAM) Plus Everolimus (RAD) With TAM Alone in Patients With Hormone-receptor-positive, HER2-negative Metastatic Breast Cancer (mBC) With Prior Exposure to Aromatase Inhibitors (Als): Implication for Research Strategies. European Journal of Cancer. 47. S331–S331. 5 indexed citations

Aparicio, Thomas, L. Teillet, D. Gargot, et al.. (2011). Geriatric factors to predict toxicity and dose-intensity reduction in FFCD 2001-02 phase III study comparing a first-line chemotherapy of LV5FU2 or FOLFIRI in treatment of metastatic colorectal cancer (mCRC) in elderly patients.. Journal of Clinical Oncology. 29(15_suppl). 9111–9111. 1 indexed citations

Fouchardière, Christelle de la, R. Largillier, Anne‐Claire Hardy‐Bessard, et al.. (2009). Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLE. Annals of Oncology. 20(12). 1959–1963. 10 indexed citations

10.

Ray‐Coquard, Isabelle, B. Weber, J Crétin, et al.. (2009). Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group. British Journal of Cancer. 100(4). 601–607. 20 indexed citations

11.

Falandry, Claire, Marc Debled, T. Delozier, et al.. (2008). Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study. Breast Cancer Research and Treatment. 116(3). 501–508. 42 indexed citations

12.

Guastalla, Jean‐Paul, Djelila Allouache, M. Combe, et al.. (2007). HER2 overexpression and amplification in advanced ovarian cancer (AOC): Treatment with trastuzumab—A GINECO study. Journal of Clinical Oncology. 25(18_suppl). 5559–5559. 6 indexed citations

13.

Colin, P., Nicolas Jovenin, G. Ganem, et al.. (2006). Effect of paclitaxel-carboplatin (PC) consolidation chemotherapy after weekly PC concurrent chemo-radiotherapy (CCR) for patients with locally advanced non-small cell lung cancer (LA-NSCLC): 3-year definitive results of the B001-phase III GERCOR-study. Journal of Clinical Oncology. 24(18_suppl). 7112–7112. 6 indexed citations

14.

Trédan, Olivier, J.-F. Geay, Sandrine Touzet, et al.. (2006). Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens. Annals of Oncology. 18(2). 256–262. 52 indexed citations

15.

Guastalla, Jean‐Paul, R. Largillier, J.-F. Geay, et al.. (2006). Docetaxel (Do) and liposomal pegylated doxorubicin in metastatic breast cancer (MBC) patients (pts): The French GINECO group experience. Journal of Clinical Oncology. 24(18_suppl). 10589–10589. 1 indexed citations

16.

Crétin, J, et al.. (1996). [PROGRESSIVE SCLERODERMA WITH RAYNAUD'S SYNDROME IN A PATIENT WITH A MITRO-AORTIC CARDIOPATHY. ASSOCIATED PULMONARY FIBROSIS?DIAGNOSTIC PROBLEM].. PubMed. 71. 104–6. 1 indexed citations

17.

Crétin, J, et al.. (1969). [Scleroderma with aortic insufficiency of the same origin].. PubMed. 223(6). 459–61.

18.

Crétin, J, et al.. (1969). [A case of reticulated confluent, Gougerot- and Carteaud papillomatosis cured by the treatment proposed by Carteaud (furacycline)].. PubMed. 76(1). 112–3. 1 indexed citations

19.

Crétin, J, et al.. (1968). [A rather unusual type of atropho-cicatricial, Besnier-Boeck-Schaumann, cutaneous sarcoidosis associated with diffuse atrophoderma suggestive of Pick-Herxheimer disease].. PubMed. 220(49). 1533–4. 1 indexed citations

20.

Crétin, J, et al.. (1968). [Latero-thoracic cutaneous metastases of an underlying pleural cancer].. PubMed. 73(5). 543–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact